探索澳大利亚门诊静脉抗生素治疗的进展。
Exploring the advancements of Australian OPAT.
作者信息
Lai Tony, Thiele Horst, Rogers Benjamin A, Hillock Nadine, Adhikari Suman, McNamara Alexander, Rawlins Matthew
机构信息
The University of Sydney School of Pharmacy, Bank Building - The University Of Sydney, 3 Parramatta Rd, Camperdown NSW 2050, Australia.
Hospital in the Home, Northern Sydney Local Health District, St Leonards, NSW, Australia.
出版信息
Ther Adv Infect Dis. 2023 Sep 21;10:20499361231199582. doi: 10.1177/20499361231199582. eCollection 2023 Jan-Dec.
Outpatient parenteral antimicrobial therapy (OPAT) in Australia has evolved from modest beginnings to a well-established health service with proven benefits in patient outcomes. This is a comprehensive review of the current state of art Australian OPAT with vignettes of the types of OPAT models of care, antimicrobial prescribing and antimicrobial use. In addition, we highlight the similarities and differences between OPAT to other countries and describe Australian OPAT experiences with COVID-19 and paediatrics. Australian OPAT continues to advance with OPAT antifungals, novel treatment options and upcoming high-impact research.
澳大利亚的门诊胃肠外抗菌治疗（OPAT）已从起步阶段发展成为一项成熟的医疗服务，在改善患者治疗效果方面已被证实具有显著益处。本文全面综述了澳大利亚OPAT的当前发展状况，并辅以OPAT护理模式、抗菌药物处方及抗菌药物使用等方面的实例。此外，我们还着重介绍了澳大利亚OPAT与其他国家之间的异同，并阐述了澳大利亚在应对新冠疫情及儿科患者时OPAT的应用经验。随着OPAT抗真菌药物、新型治疗方案的出现以及即将开展的具有重大影响的研究，澳大利亚的OPAT将持续发展。
Zotero 插件